CCL2 and breast carcinoma: While chronic hypoxia downregulates the CCL2 expression in ovarian cancer [12], and HUVEC [13], the CCL2 upregulation was evident in gastric cancer [14], breast cancer cells [15], dermal fibroblasts [16], and primary mouse astrocytes [17].